Evofem Biosciences Inc
Change company Symbol lookup
Select an option...
EVFM Evofem Biosciences Inc
MTX Minerals Technologies Inc
NS-C NuStar Energy LP
DQ Daqo New Energy Corp
ITRI Itron Inc
PSA-I Public Storage
HSKA Heska Corp
SLGN Silgan Holdings Inc
DYNA Dynastar Holdings Inc
ELMWQ Electric Last Mile Solutions Equity Warrant Exp 24 Aug 2027 *W EXP 08/24/2027
Go

Health Care : Pharmaceuticals | Small Cap Value
Company profile

Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company. It is engaged in developing and commercializing products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). Its product, Phexxi vaginal gel, is a hormone-free, woman-controlled, on-demand prescription contraceptive gel for women. Its lead clinical program is evaluating Phexxi (using the investigational name EVO100) for the prevention of chlamydia and gonorrhea in women. EVO200 vaginal gel (EVO200), its investigational candidate for the reduction of recurrent bacterial vaginosis (BV), uses the same vaginal potential of hydrogen (pH) modulator platform as Phexxi. It also focuses on developing Multipurpose Prevention Technology (MPT) vaginal gel for indications, including the prevention of human immunodeficiency virus (HIV) in women through Orion Biotechnology Canada Ltd.

Closing Price
$0.1702
Day's Change
-0.0123 (-6.74%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.20
Day's Low
0.17
Volume
(Light)
Volume:
1,112,181

10-day average volume:
2,771,113
1,112,181

Display:

Providers:

UpdateCancel
4 providers
June 28, 2022
Evofem Biosciences stock reverses lower, falls 10.3% after being up as much as 40.2% earlier

(END) Dow Jones Newswires June 28, 2022 13:13 ET (17:13 GMT) (MarketWatch)

June 27, 2022
Evofem's stock is still up after Friday's Supreme Court decision

Shares of Evofem Biosciences Inc. (EVFM) soared 164.6% in trading on Monday in a rally that began Friday when the Supreme Court decision striking down Roe v. Wade was announced. Evofem makes a birth-control product with a four-year shelf life...(MarketWatch)

Evofem's stock is still soaring after Friday's Supreme Court decision

Shares of Evofem Biosciences Inc. (EVFM) soared 164.6% in trading on Monday in a rally that began Friday when the Supreme Court decision striking down Roe v. Wade was announced. Evofem makes a birth-control product with a four-year shelf life...(MarketWatch)

June 24, 2022
Evofem's stock jumps 30% after Supreme Court decision on Roe v. Wade

Shares of Evofem Biosciences Inc. (EVFM) soared 30.6% in trading on Friday, hours after the Supreme Court decision striking down Roe v. Wade was announced. Experts have speculated that the court's decision could lead to restrictions on birth...(MarketWatch)

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.